Purchase Order 36C26326P0164

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC on December 19, 2025, with a completion date of December 22, 2025. This contract, classified as TAVR (Transcatheter Aortic Valve Replacement), represents a non-set-aside procurement for specialized cardiovascular medical devices to be delivered to Minneapolis, Minnesota. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized as a self-certified small disadvantaged business, is the sole manufacturer of the advanced heart valve products required under this award.

Edwards Lifesciences LLC maintains a substantial existing relationship with the VA, including two significant Indefinite Delivery Contracts valued at $2.5 million and $1.25 million respectively, which support the procurement of specialized cardiac devices including SAPIEN 3 transcatheter heart valves, INSPIRIS RESILIA aortic valves, and related annuloplasty systems across multiple VISNs. This purchase order award continues the company's critical role in providing advanced cardiovascular technologies to support veteran healthcare through the VA's cardiac surgical programs. The contract type and pricing structure reflect the VA's standard procurement methodology for specialized medical devices with firm fixed-price terms.